ACHV: Achieve Life Sciences, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 150.37
Enterprise Value ($M) 151.49
Book Value ($M) -1.45
Book Value / Share -0.04
Price / Book -103.84
NCAV ($M) -3.84
NCAV / Share -0.11
Price / NCAV -39.19

Profitability (mra)
Return on Invested Capital (ROIC) -1.95
Return on Assets (ROA) -1.43
Return on Equity (ROE) -67.30

Liquidity (mrq)
Quick Ratio 0.82
Current Ratio 0.82

Balance Sheet (mrq) ($M)
Current Assets 16.98
Assets 19.37
Liabilities 20.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -27.25
Net Income -29.82
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -24.48
Cash from Investing -0.02
Cash from Financing 15.28

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-11 13G Franklin Resources Inc 12.00
02-27 13G Callahan Patrick J. III 9.90
06-02 13G/A Contrarian Alpha, LP 9.70
2023-04-18 13G Dialectic Capital Management, Lp 19.99 1.24

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 2054916.7 FORM 10-Q
2023-05-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 26,847 429,102 6.26
2024-04-30 10,265 62,109 16.53
2024-04-29 3,016 15,734 19.17
2024-04-26 11,356 16,466 68.97

(click for more detail)

Similar Companies
ABIO – ARCA biopharma, Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc. ACST – Acasti Pharma Inc.
ACXP – Acurx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io